Up to 50% of patients in the ICU will develop acute kidney injury (AKI)—now, there's a way to test for AKI risk
Duration: 4 Minutes
Acute kidney injury (AKI) is one of the most significant and potentially deadly diseases affecting patients in the ICU. Now hear from industry experts about how the first commercially available test is allowing for early AKI risk assessment in these ICU patients. The NephroCheck®Test allows clinicians to identify patients at risk to develop moderate to severe AKI and to implement strategies which can help prevent kidney damage or death.
- Understand the seriousness of AKI
- Identify the historic challenges associated with assessing AKI risk
- Learn how NephroCheck test results can help clinicians identify, stratify and mitigate a patient’s risk of AKI
Presenters in this video:
- Jeffery Vender, MD
Anesthesiologist & Critical Care Physician, North Shore Hospital Health System, Evanston, IL
- Harold M. Szerlip, MD
Nephrologist & Director, Renal Division, Baylor University Medical Center, Dallas, TX
- Peter McCullough, MD
Cardiologist, Vice Chief of Medicine, Baylor University Medical Center, Dallas, TX
This promotional educational activity is brought to you by Ortho Clinical Diagnostics and is not certified for Continuing Medical Education (CME). The speakers are presenting on behalf of Ortho Clinical Diagnostics and must present information in accordance with applicable and/or local regulatory country requirements.